1. Home
  2. ONFOW vs NAMSW Comparison

ONFOW vs NAMSW Comparison

Compare ONFOW & NAMSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONFOW
  • NAMSW
  • Stock Information
  • Founded
  • ONFOW N/A
  • NAMSW N/A
  • Country
  • ONFOW United States
  • NAMSW Netherlands
  • Employees
  • ONFOW 12
  • NAMSW 29
  • Industry
  • ONFOW Computer Software: Programming Data Processing
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • Sector
  • ONFOW Technology
  • NAMSW Health Care
  • Exchange
  • ONFOW Nasdaq
  • NAMSW Nasdaq
  • Market Cap
  • ONFOW N/A
  • NAMSW N/A
  • IPO Year
  • ONFOW 2022
  • NAMSW N/A
  • Fundamental
  • Price
  • ONFOW $0.14
  • NAMSW $8.35
  • Analyst Decision
  • ONFOW
  • NAMSW
  • Analyst Count
  • ONFOW 0
  • NAMSW 0
  • Target Price
  • ONFOW N/A
  • NAMSW N/A
  • AVG Volume (30 Days)
  • ONFOW N/A
  • NAMSW N/A
  • Earning Date
  • ONFOW N/A
  • NAMSW N/A
  • Dividend Yield
  • ONFOW N/A
  • NAMSW N/A
  • EPS Growth
  • ONFOW N/A
  • NAMSW N/A
  • EPS
  • ONFOW N/A
  • NAMSW N/A
  • Revenue
  • ONFOW N/A
  • NAMSW N/A
  • Revenue This Year
  • ONFOW N/A
  • NAMSW N/A
  • Revenue Next Year
  • ONFOW N/A
  • NAMSW N/A
  • P/E Ratio
  • ONFOW N/A
  • NAMSW N/A
  • Revenue Growth
  • ONFOW N/A
  • NAMSW N/A
  • 52 Week Low
  • ONFOW N/A
  • NAMSW N/A
  • 52 Week High
  • ONFOW N/A
  • NAMSW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ONFOW N/A
  • NAMSW 44.39
  • Support Level
  • ONFOW N/A
  • NAMSW $9.40
  • Resistance Level
  • ONFOW N/A
  • NAMSW $10.14
  • Average True Range (ATR)
  • ONFOW 0.00
  • NAMSW 0.36
  • MACD
  • ONFOW 0.00
  • NAMSW -0.05
  • Stochastic Oscillator
  • ONFOW 0.00
  • NAMSW 3.25

About ONFOW Onfolio Holdings Inc. Warrant

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: